Back to Results
First PageMeta Content
Pharmacology / Nose / Immunology / Allergic rhinitis / Type 1 hypersensitivity / Rhinitis / Nasal congestion / Clinical trial / Allergen / Medicine / Allergology / Health


Draft Guidance Document - Data Requirements for Safety and Effictiveness of Subsequent Market Entry Steroid Nasal Products for Use in the Treatment of Allergic Rhinitis
Add to Reading List

Document Date: 2013-06-24 11:52:36

Open Document

File Size: 117,90 KB

Share Result on Facebook

City

Ottawa / /

Country

Canada / /

/

Event

Product Issues / /

Facility

Health Canada Building / /

/

IndustryTerm

pharmaceutical characteristics / treatment for the symptoms / to combination products / study protocol / nasal products / health products / therapeutic product / pharmaceutical quality / steroid nasal product / Allergy Therapies / food / /

MedicalCondition

mild intermittent asthma / Health Canada Guidance Document Background Rhinitis / headache / rhinorrhoea / nasal obstruction / rhinitis / nasal itching / Allergy / nasal obstruction / Allergic Rhinitis / seasonal allergic rhinitis / significant diseases / asthma / /

Organization

Health Products and Food Branch / Bureau of Cardiology / Allergy and Neurological Sciences Therapeutic Products Directorate / Science Advisory Committee on Respiratory and Allergy Therapies / Bureau of Cardiology / Therapeutic Products Directorate / office of Sciences / /

/

Position

investigator / Prime Minister / average AM+PM / Minister of Public Works / General / Allergic Rhinitis Minister / /

Product

headache / concentration / /

ProgrammingLanguage

C / /

ProvinceOrState

Ontario / /

Technology

study protocol / /

SocialTag